Co-transduction of lentiviral and adenoviral vectors for co-delivery of growth factor and shRNA genes in mesenchymal stem cells-based chondrogenic system

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 9, 2015, Pages 1036-1045

  Zhang, Feng ^a   Yao, Yongchang ^a,b,c   Su, Kai ^a   Fang, Yu ^a   Citra, Fudiman ^a   Wang, Dong An ^a  

^a Nanyang Technological University   (Singapore)

^b SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^c National Engineering Research Center for Tissue Restoration and Reconstruction   (China)

Author keywords

Adenoviral vector; Chondrogenesis; Gene delivery; Lentiviral vector; RNAi; Synovial mesenchymal stem cells (SMSCs); TGF 3; Type I collagen

Indexed keywords

BACTERIOPHAGES; CARTILAGE; CELL CULTURE; COLLAGEN; GENE EXPRESSION; STEM CELLS; VECTORS;

ADENOVIRAL VECTORS; CHONDROGENESIS; GENE DELIVERY; LENTIVIRAL VECTOR; MESENCHYMAL STEM CELL; RNAI; SYNOVIAL MESENCHYMAL STEM CELL; TGFΒ3; TYPE I COLLAGEN; TYPE-I COLLAGEN;

GENE TRANSFER;

ADENOVIRUS VECTOR; AGGRECAN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 10; COLLAGEN TYPE 2; GAG PROTEIN; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA3; COLLAGEN; GLYCOSAMINOGLYCAN; SMALL INTERFERING RNA;

AGGRECAN GENE; ANIMAL CELL; ARTICLE; CHONDROGENESIS; COL I ALPHA1 GENE; COL II GENE; COL X GENE; COMP GENE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE REPRESSION; MESENCHYMAL STEM CELL; MOLECULARLY TARGETED THERAPY; NONHUMAN; PIG; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL MESENCHYMAL STEM CELL; TGF BETA3 GENE; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; ADENOVIRIDAE; ANIMAL; CELL CULTURE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; LENTIVIRINAE; MESENCHYMAL STROMA CELL; METABOLISM; POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; CHONDROGENESIS; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENETIC VECTORS; GLYCOSAMINOGLYCANS; LENTIVIRUS; MESENCHYMAL STROMAL CELLS; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SWINE; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84941600568     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1656     Document Type: Article

References (34)

1. Ameer GA, Mahmood TA, Langer R. 2002; A biodegradable composite scaffold for cell transplantation. J Orthop Res 20(1): 16-19.
2. Bert JM. 1993; Role of abrasion arthroplasty and debridement in the management of osteoarthritis of the knee. Rheum Dis Clin N Am 19(3): 725-739.
3. Bouard D, Alazard-Dany D, Cosset FL. 2009; Viral vectors: from virology to transgene expression. Br J Pharmacol 157(2): 153-165.
4. Boulaiz H, Marchal JA, Prados J, et al. 2005; Non-viral and viral vectors for gene therapy. Cell Mol Biol 51(1): 3-22.
5. Chang JC, Hsu SH, Chen DC. 2009; The promotion of chondrogenesis in adipose-derived adult stem cells by an RGD-chimeric protein in 3D alginate culture. Biomaterials 30(31): 6265-6275.
6. Chen HC, Sung LY, Lo WH, et al. 2008; Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene Ther 15(4): 309-317.
7. De Bari C, Dell'Accio F, Tylzanowski P, et al. 2001; Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44(8): 1928-1942.
8. Fan J, Varshney RR, Ren L, et al. 2009; Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev 15(1): 75-86.
9. Farndale RW, Buttle DJ, Barrett AJ. 1986; Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883(2): 173-177.
10. Freed LE, Marquis JC, Nohria A, et al. 1993; Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 27(1): 11-23.
11. Freed LE, Hollander AP, Martin I, et al. 1998; Chondrogenesis in a cell-polymer bioreactor system. Exp Cell Res 240(1): 58-65.
12. Goodrich LR, Hidaka C, Robbins PD, et al. 2007; Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 89(5): 672-685.
13. Hao J, Yao Y, Varshney RR, et al. 2008; Gene transfer and living release of transforming growth factor-β3 for cartilage tissue engineering applications. Tissue Eng Part C Methods 14(4): 273-280.
14. Hollander AP, Heathfield TF, Webber C, et al. 1994; Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 93(4): 1722-1732.
15. James AW, Xu Y, Lee JK, et al. 2009; Differential effects of TGF-β1 and TGF-β3 on chondrogenesis in posterofrontal cranial suture-derived mesenchymal cells in vitro. Plast Reconstr Surg 123(1): 31-43.
16. Johnson LL. 1986; Arthroscopic abrasion arthroplasty historical and pathologic perspective: present status. Arthroscopy 2(1): 54-69.
17. Kim YJ, Sah RL, Doong JY, et al. 1988; Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174(1): 168-176.
18. Kumai T, Takakura Y, Higashiyama I, et al. 1999; Arthroscopic drilling for the treatment of osteochondral lesions of the talus. J Bone Joint Surg Am 81(9): 1229-1235.
19. Marlovits S, Aldrian S, Tichy B, et al. 2009; [Biomaterial for autologous chondrocyte transplantation]. Orthopade 38(11): 1045-1052.
20. Na K, Kim S, Woo DG, et al. 2007; Synergistic effect of TGFβ3 on chondrogenic differentiation of rabbit chondrocytes in thermo-reversible hydrogel constructs blended with hyaluronic acid by in vivo test. J Biotechnol 128(2): 412-422.
21. Pagnotto MR, Wang Z, Karpie JC, et al. 2007; Adeno-associated viral gene transfer of transforming growth factor-β1 to human mesenchymal stem cells improves cartilage repair. Gene Ther 14(10): 804-813.
22. Pfeifer A. 2006; Lentiviral transgenesis - a versatile tool for basic research and gene therapy. Curr Gene Ther 6(4): 535-542.
23. Porteus MH, Connelly JP, Pruett SM. 2006; A look to future directions in gene therapy research for monogenic diseases. PLoS Genet 2(9): e133.
24. Schagemann JC, Erggelet C, Chung HW, et al. 2009; Cell-laden and cell-free biopolymer hydrogel for the treatment of osteochondral defects in a sheep model. Tissue Eng Part A 15(1): 75-82.
25. Shapiro F, Koide S, Glimcher MJ. 1993; Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 75(4): 532-553.
26. Shoji Y, Nakashima H. 2004; Current status of delivery systems to improve target efficacy of oligonucleotides. Curr Pharm Des 10(7): 785-796.
27. Steinert AF, Noth U, Tuan RS. 2008; Concepts in gene therapy for cartilage repair. Injury 39(suppl 1): S97-113.
28. Varshney RR, Zhou R, Hao J, et al. 2010; Chondrogenesis of synovium-derived mesenchymal stem cells in gene-transferred co-culture system. Biomaterials 31(26): 6876-6891.
29. Yao Y, Zhang F, Zhou R, et al. 2010; Effects of combinational adenoviral vector-mediated TGFβ3 transgene and shRNA silencing type I collagen on articular chondrogenesis of synovium-derived mesenchymal stem cells. Biotechnol Bioeng 106(5): 818-828.
30. Yao Y, Zhang F, Pang PX, et al. 2011; In vitro study of chondrocyte redifferentiation with lentiviral vector-mediated transgenic TGFβ3 and shRNA suppressing type I collagen in three-dimensional culture. J Tissue Eng Regen Med 5(8): e219-227.
31. Yun K, Moon HT. 2008; Inducing chondrogenic differentiation in injectable hydrogels embedded with rabbit chondrocytes and growth factor for neocartilage formation. J Biosci Bioeng 105(2): 122-126.
32. Zhang F, Yao Y, Hao J, et al. 2010; A dual-functioning adenoviral vector encoding both transforming growth factor-β3 and shRNA silencing type I collagen: construction and controlled release for chondrogenesis. J Control Release 142(1): 70-77.
33. Zhang F, Yao Y, Hao J, et al. 2010; A dual-functioning adenoviral vector encoding both transforming growth factor-β3 and shRNA silencing type I collagen: construction and controlled release for chondrogenesis. J Control Release 142(1): 70-77.
34. Zhang F, Yao Y, Zhou R, et al. 2011; Optimal construction and delivery of dual-functioning lentiviral vectors for type I collagen-suppressed chondrogenesis in synovium-derived mesenchymal stem cells. Pharm Res 28(6): 1338-1348.